NCT00840086 - Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Congenital Bleeding DisorderHaemophilia A

Interventions

DRUG

turoctocog alfa

Subjects will receive bleeding preventive treatment (home treatment with self-injection i.v.) with turoctocog alfa at a dose of 20-40 IU/kg body weight every second day or 20-50 IU/kg body weight three times per week at the investigator's discretion.

Trial Locations (63)

100

Novo Nordisk Investigational Site, Taipei

2100

Novo Nordisk Investigational Site, Copenhagen

4012

Novo Nordisk Investigational Site, Debrecen

8091

Novo Nordisk Investigational Site, Zurich

10249

Novo Nordisk Investigational Site, Berlin

11000

Novo Nordisk Investigational Site, Belgrade

11070

Novo Nordisk Investigational Site, Belgrade

18000

Novo Nordisk Investigational Site, Nis

Novo Nordisk Investigational Site, Niš

20124

Novo Nordisk Investigational Site, Milan

21000

Novo Nordisk Investigational Site, Novi Sad

28046

Novo Nordisk Investigational Site, Madrid

30322

Novo Nordisk Investigational Site, Atlanta

30625

Novo Nordisk Investigational Site, Hanover

30912

Novo Nordisk Investigational Site, Augusta

33607

Novo Nordisk Investigational Site, Tampa

35100

Novo Nordisk Investigational Site, Bornova-IZMIR

35392

Novo Nordisk Investigational Site, Giessen

38163

Novo Nordisk Investigational Site, Memphis

41380

Novo Nordisk Investigational Site, İzmit

45229

Novo Nordisk Investigational Site, Cincinnati

45404

Novo Nordisk Investigational Site, Dayton

46026

Novo Nordisk Investigational Site, Valencia

46260

Novo Nordisk Investigational Site, Indianapolis

50134

Novo Nordisk Investigational Site, Florence

50400

Novo Nordisk Investigational Site, Kuala Lumpur

52242

Novo Nordisk Investigational Site, Iowa City

52621

Novo Nordisk Investigational Site, Tel Litwinsky

53127

Novo Nordisk Investigational Site, Bonn

55319

Novo Nordisk Investigational Site, Samsun

72202

Novo Nordisk Investigational Site, Little Rock

76104

Novo Nordisk Investigational Site, Fort Worth

90806

Novo Nordisk Investigational Site, Long Beach

97239

Novo Nordisk Investigational Site, Portland

99204

Novo Nordisk Investigational Site, Spokane

191119

Novo Nordisk Investigational Site, Saint Petersburg

1670035

Novo Nordisk Investigational Site, Suginami-ku, Tokyo

4208660

Novo Nordisk Investigational Site, Shizuoka-shi, Shizuoka

68198-2168

Novo Nordisk Investigational Site, Omaha

07102

Novo Nordisk Investigational Site, Newark

19134-1095

Novo Nordisk Investigational Site, Philadelphia

02903

Novo Nordisk Investigational Site, Providence

37232-9830

Novo Nordisk Investigational Site, Nashville

20211-030

Novo Nordisk Investigational Site, Rio de Janeiro

21 000

Novo Nordisk Investigational Site, Split

Novo Nordisk Investigational Site, Novi Sad

10 000

Novo Nordisk Investigational Site, Zagreb

H-1134

Novo Nordisk Investigational Site, Budapest

734 8551

Novo Nordisk Investigational Site, Hiroshima-shi, Hiroshima

173 8606

Novo Nordisk Investigational Site, Itabashi-ku, Tokyo

634 8522

Novo Nordisk Investigational Site, Kashihara-shi, Nara

371-8511

Novo Nordisk Investigational Site, Maebashi-shi, Gunma

466 8560

Novo Nordisk Investigational Site, Nagoya-shi, Aichi

329 0498

Novo Nordisk Investigational Site, Shimotsuke-shi, Tochigi

160 0023

Novo Nordisk Investigational Site, Shinjuku-ku, Tokyo

01130

Novo Nordisk Investigational Site, Adana

01010

Novo Nordisk Investigational Site, Antalya

NW3 2QG

Novo Nordisk Investigational Site, London

SE1 7EH

Novo Nordisk Investigational Site, London

M13 9WL

Novo Nordisk Investigational Site, Manchester